High-Risk Myelodysplastic Syndromes: Chemotherapy, Transplantation, and Beyond Usama GergisUsama Wissa OriginalPaper 12 January 2010 Pages: 1 - 8
Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More? Rami S. KomrokjiJeffrey E. LancetAlan F. List OriginalPaper 06 January 2010 Pages: 9 - 14
New Drugs for the Treatment of Myelofibrosis Ruben A. Mesa OriginalPaper 08 January 2010 Pages: 15 - 21
JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms Alessandro M. Vannucchi OriginalPaper 14 January 2010 Pages: 22 - 28
New Agents in Chronic Lymphocytic Leukemia Thomas S. Lin OriginalPaper 05 January 2010 Pages: 29 - 34
Eradicating Minimal Residual Disease in Chronic Lymphocytic Leukemia: Should This Be the Goal of Treatment? Abraham M. VargheseAndy C. RawstronPeter Hillmen OriginalPaper 12 January 2010 Pages: 35 - 44
Challenges in the Frontline Treatment of Patients With Chronic Lymphocytic Leukemia Nicole Lamanna OriginalPaper 15 January 2010 Pages: 45 - 51